MET and prostate carcinoma: In addition, a noted increase in the amount of MET protein, another known target of miR-125b expression, would lead to an increase in RAS signaling thru the pMEK/pERK pathway, also shown to be increased in prostate cancer and supported by our proteomic data (Table 3).